Significant advancements have been achieved in the field of peptide drug development in recent years, resulting in a market presence of over 80 available peptide drugs. Peptide drugs are highly specific, have superior efficacy and safety profiles. At present, peptide drugs are available for various therapeutic areas including, diabetes, cancer, osteoporosis, HIV infection, chronic pain etc.
Aragen provides custom peptide synthesis services for its customers across the globe including leading pharmaceutical, biotech, life-science, and healthcare companies. Our custom peptide synthesis service offers numerous options for synthesis platforms, purity levels, and modifications to meet a variety of research needs. With a peptide portfolio that encompasses linear, branched, cyclic peptides, peptide conjugates and modified peptides, we enable synthesis of focused peptides libraries to support discovery programs. Our expertise in solid and solution phase synthesis allows us to generate peptide mimics and complex peptides to desired scales.
Custom Peptide Synthesis
Expertise in Custom Peptide synthesis :
Expertise in small to medium length molecular peptides (>50 AA).
Extensive technology using solid phase, solution phase, hybrid technology, TAG assisted synthesis and native chemical ligation.
Expertise in linear, cyclic, stapled peptide etc.
Analytical Expertise :
Well versed with purification techniques on both chiral and achiral platforms.
SFC instrument coupled with MS, to purify chiral and achiral compounds from mg to kg scale.
Semi prep-HPLCs with diverse detectors and columns.
Equipped with characterization techniques like HRMS, LC-MS (QQQ) and NMR.
Other key instruments include DSC, TGA and ICPMS available for characterization.
Infrastructure and Delivery :
Working with global pharma companies for developing robust, safe, scalable, and economical process.
Successfully delivered various peptide molecules from gram to multi-kilogram scale.
Team of experts in peptide chemistry for screening, lab development, pilot, and plant manufacturing.
Proven track record in technical problem solving for leading global pharma and biotech companies.
Expertise in using various protection, deprotection & coupling reagents.
Experience in resolving epimerization issues.
DoE approaches for reducing process development timelines.
Adopting green chemistry principles while developing the process.
Learn more about our end-to-end capabilities
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. Your privacy is important to us and your personal information will be treated confidentially. Click here to view our Privacy Policy.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.